---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-178719"
form_type: "8-K"
ticker: "WOOF"
cik: "0001826470"
company_name: "Petco Health & Wellness Company, Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T15:03:00.215445+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Petco appoints Iris Yen and David Lubek to Board following resignations of Pereira and Biagosch

## Summary
- Jennifer Pereira resigned from Board effective June 23, 2023; Maximilian Biagosch resigned effective June 29, 2023, both not due to any disagreement.
- Board appointed Iris Yen (VP at Nike) as Class I director and David Lubek (MD at CPP Investments) as Class II director effective June 29, 2023.
- Yen appointed to Audit Committee replacing Gary Briggs; Lubek appointed to Nominating and Corporate Governance Committee; Mary Sullivan moves to Compensation Committee.
- Annual RSU grant for independent directors increased from $150k to $165k effective July 6, 2023; Yen also receives initial $120k RSU grant.
- Yen and Lubek designated by controlling stockholder Scooby Aggregator, LP per Stockholder's Agreement.

## SEC filing metadata
- accession: 0001193125-23-178719
- form_type: 8-K
- ticker: WOOF
- cik: 0001826470
- company_name: Petco Health & Wellness Company, Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/0001193125-23-178719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/d657096d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-178719
- JSON: https://secwatch.observer/filing/0001193125-23-178719.json
- Plain text: https://secwatch.observer/filing/0001193125-23-178719.txt

## Key facts
- Executive change
  Jennifer Pereira resigned as Director at Petco Health & Wellness Company, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 23, 2023, Jennifer Pereira resigned from the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/0001193125-23-178719-index.htm
- Executive change
  Iris Yen was appointed as Class I Director at Petco Health & Wellness Company, Inc..
  - Action: appointed
  - Role: Class I Director
  source text: on June 29, 2023, the Board appointed Iris Yen as an independent Class I director to hold office until the next election of Class I directors and until her successor shall have been duly elected and qualified or until her earlier death, resignation, removal, retirement, or disqualification.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/0001193125-23-178719-index.htm
- Executive change
  David Lubek was appointed as Class II Director at Petco Health & Wellness Company, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: on June 29, 2023, the Board appointed David Lubek as a Class II director to hold office until the next election of Class II directors and until his successor shall have been duly elected and qualified or until his earlier death, resignation, removal, retirement, or disqualification.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/0001193125-23-178719-index.htm
- Executive change
  Maximilian Biagosch resigned as Director at Petco Health & Wellness Company, Inc..
  - Action: resigned
  - Role: Director
  source text: Also on June 23, 2023, Maximilian Biagosch provided notice to the Board of his intent to resign from the Board, effective June 29, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826470/000119312523178719/0001193125-23-178719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.